Structure Therapeutics Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -51.38M-89.62M-122.54M
Depreciation and Depletion 0.28M0.30M1.00M
Share-based Compensation 2.51M8.19M18.79M
Gains from Investment Securities 0.20M5.51M16.60M
Cash from Operations -46.12M-79.49M-116.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.91M5.97M18.46M
Depreciation & Amortization (CF) 0.28M0.30M1.00M
Change in Working Capital
Change in Account Payables 2.15M-0.86M3.31M
Change in Accured Expenses 1.54M12.16M7.72M
Investing Activities
Capital Expenditures 0.15M2.17M1.29M
Change in Acquisitions & Divestments 61.50M151.18M344.90M
Cash from Investing Activities -62.11M-268.34M-358.91M
Financing Activities
Other financing activities 2.51M21.57M1.80M
Change in Capital Stock
Shares Issued 0.03M300.00M514.57M
Shares Repurchased 199.97M
Preferred Shares Issued 31.50M
Misc.
Cash from Financing Activities 29.01M451.53M515.26M
Change in Cash -79.21M103.70M39.72M
Free Cash Flow -46.27M-81.66M-117.93M
Net Cash Flow -79.21M103.70M39.72M